Roles for Crk in Cancer Metastasis and Invasion

Genes and Cancer

Volumn 3, Issue 5-6, 2012, Pages 334-340

  Tsuda, Masumi ^a   Tanaka, Shinya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Crk adaptor protein; human cancer; invasion; metastasis

Indexed keywords

ABELSON KINASE; ADAPTOR PROTEIN; CATENIN; CRK ASSOCIATED SUBSTRATE PROTEIN; CT10 REGULATOR OF KINASE PROTEIN; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAXILLIN; PROTEIN P120; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DISEASE ACTIVITY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; METASTASIS; NONHUMAN; PHAGOCYTOSIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SARCOMA; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA;

EID: 84875493705     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912458687     Document Type: Article

References (53)

1. Mayer BJ,Hamaguchi M,Hanafusa H.A novel viral oncogene with structural similarity to phospholipase C.Nature. 1988;332:272-5.
2. Matsuda M,Tanaka S,Nagata S,Kojima A,Kurata T,Shibuya M.Two species of human CRK cDNA encode proteins with distinct biological activities.Mol Cell Biol. 1992;12:3482-9.
3. Reichman CT,Mayer BJ,Keshav S,Hanafusa H.The product of the cellular crk gene consists primarily of SH2 and SH3 regions.Cell Growth Differ. 1992;3:451-60.
4. ten Hoeve J,Morris C,Heisterkamp N,Groffen J.Isolation and chromosomal localization of CRKL, a human crk-like gene.Oncogene. 1993;8:2469-74.
5. Muralidharan V,Dutta K,Cho J, et al.Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II.Biochemistry. 2006;45:8874-84.
6. Reichman C,Singh K,Liu Y,Singh S,Li H,Fajardo JE, et al.Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.Oncogene. 2005;24:8187-99.
7. Prosser S,Sorokina E,Pratt P,Sorokin A.CrkIII: a novel and biologically distinct member of the Crk family of adaptor proteins.Oncogene. 2003;22:4799-806.
8. Birge RB,Kalodimos C,Inagaki F,Tanaka S.Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.Cell Commun Signal. 2009;7:13.
9. Sriram G,Birge RB.Emerging roles for crk in human cancer.Genes Cancer. 2010;1:1132-9.
10. Linghu H,Tsuda M,Makino Y, et al.Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS.Oncogene. 2006;25:3547-56.
11. Watanabe T,Tsuda M,Makino Y, et al.Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.Mol Cancer Res. 2006;4:499-510.
12. Wang L,Tabu K,Kimura T, et al.Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.Biochem Biophys Res Commun. 2007;362:976-81.
13. Crawford M,Brawner E,Batte K, et al.MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.Biochem Biophys Res Commun. 2008;373:607-12.
14. Feng RH,Chen XH,Yu YY, et al.miR-126 functions as a tumour suppressor in human gastric cancer.Cancer Letters. 2010;298:50-63.
15. Tsuda M,Makino Y,Iwahara T, et al.Crk associates with ERM proteins and promotes cell motility toward hyaluronic acid.J Biol Chem. 2004;279:46843-50.
16. Takino T,Nakada M,Miyamori H,Yamashita J,Yamada KM,Sato H.CrkI adapter protein modulates cell migration and invasion in glioblastoma.Cancer Res. 2003;63:2335-7.
17. Yamada S,Yanamoto S,Kawasaki G, et al.Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinoma.Cancer Letters. 2011;303:84-91.
18. Kim LC,Song L,Haura EB.Src kinases as therapeutic targets for cancer.Nat Rev Clin Oncol. 2009;6:587-95.
19. Huang M,Anand S,Murphy EA, et al.EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.Oncogene. 2011;:.
20. Hingorani P,Zhang WD,Gorlick R,Kolb EA.Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.Clin Cancer Res. 2009;15:3416-22.
21. Watanabe T,Tsuda M,Makino Y, et al.Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.Cell Res. 2009;19:638-50.
22. Buettner R,Mesa T,Vultur A,Lee F,Jove R.Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.Mol Cancer Res. 2008;6:1766-74.
23. Tikhmyanova N,Little JL,Golemis EA.CAS proteins in normal and pathological cell growth control.Cell Mol Life Sci. 2010;67:1025-48.
24. Kirsch K,Kensinger M,Hanafusa H,August A.A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.BMC Cell Biol. 2002;3:18.
25. Brabek J,Constancio SS,Siesser PF,Shin NY,Pozzi A,Hanks SK.Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of Src-transformed cells.Mol Cancer Res. 2005;3:307-15.
26. Bouton AH,Riggins RB,Bruce-Staskal PJ.Functions of the adapter protein Cas: signal convergence and the determination of cellular responses.Oncogene. 2001;20:6448-58.
27. Chodniewicz D,Klemke RL.Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold.Biochim Biophys Acta Mol Cell Res. 2004;1692:63-76.
28. Kain KH,Gooch S,Klemke RL.Cytoplasmic c-Abl provides a molecular "rheostat" controlling carcinoma cell survival and invasion.Oncogene. 2003;22:6071-80.
29. Singh MK,Dadke D,Nicolas E, et al.A novel Cas family member, HEPL, regulates FAK and cell spreading.Mol Biol Cell. 2008;19:1627-36.
30. Dorssers LC,Grebenchtchikov N,Brinkman A, et al.The prognostic value of BCAR1 in patients with primary breast cancer.Clin Cancer Res. 2004;10:6194-202.
31. Brinkman A,van der Flier S,Kok EM,Dorssers LC.BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.J Natl Cancer Inst. 2000;92:112-20.
32. Spencer KS,Graus-Porta D,Leng J,Hynes NE,Klemke RL.ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.J Cell Biol. 2000;148:385-97.
33. Cabodi S,Tinnirello A,Di Stefano P, et al.p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.Cancer Res. 2006;66:4672-80.
34. Kumbrink J,Kirsch KH.Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.Neoplasia. 2012;14:108-20.
35. Near RI,Zhang Y,Makkinje A,Vanden Borre P,Lerner A.AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.J Cell Physiol. 2007;212:655-65.
36. Riggins RB,Quilliam LA,Bouton AH.Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.J Biol Chem. 2003;278:28264-73.
37. Tornillo G,Bisaro B,Camacho-Leal MeP.p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.et al Eur J Cell Biol. 2011;90:237-48.
38. Cunningham-Edmondson AC,Hanks SK.p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.Breast Cancer (London). 2009;2009:39-52.
39. Soni S,Lin BT,August A,Nicholson RI,Kirsch KH.Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.J Cell Biochem. 2009;107:364-75.
40. Wendt MK,Smith JA,Schiemann WP.p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.J Biol Chem. 2009;284:34145-56.
41. Dai Y,Qi L,Zhang X,Li Y,Chen M,Zu X.CrkI and p130Cas complex regulates the migration and invasion of prostate cancer cells.Cell Biochem Funct. 2011;29:625-9.
42. Turner CE.Paxillin and focal adhesion signalling.Nat Cell Biol. 2000;2:E231-6.
43. Birge RB,Fajardo JE,Reichman C, et al.Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.Mol Cell Biol. 1993;13:4648-56.
44. Altun-Gultekin ZF,Chandriani S,Bougeret C, et al.Activation of Rho-dependent cell spreading and focal adhesion biogenesis by the v-Crk adaptor protein.Mol Cell Biol. 1998;18:3044-58.
45. Azuma K,Tanaka M,Uekita T, et al.Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma.Oncogene. 2005;24:4754-64.
46. Shi JN,Wang S,Zhao EY,Shi L,Xu X,Fang M.Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma.J Oral Pathol Med. 2010;39:548-51.
47. Fernandis AZ,Prasad A,Band H,Klosel R,Ganju RK.Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.Oncogene. 2004;23:157-67.
48. Valles AM,Beuvin M,Boyer B.Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells.J Biol Chem. 2004;279:44490-6.
49. Zhao F,Siu MKY,Jiang LL, et al.Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.Histopathology. 2011;59:1163-72.
50. Mortazavi F,Dubinett S,Rettig M.c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells.Clin Exp Metastasis. 2011;28:391-404.
51. Zandy NL,Pendergast AM.Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases.Cell Cycle. 2008;7:444-8.
52. Hasegawa H,Senga T,Ito S,Iwamoto T,Hamaguchi M.A role for AP-1 in matrix metalloproteinase production and invadopodia formation of v-Crk-transformed cells.Exp Cell Res. 2009;315:1384-92.
53. Toffoli S,Delaive E,Dieu M,Feron O,Raes M,Michiels C.NDRG1 and CRK-I/II are regulators of endothelial cell migration under intermittent hypoxia.Angiogenesis. 2009;12:339-54.